ALTERED SARCOLEMMAL CALCIUM-CHANNEL DENSITY AND CA2+-PUMP ATPASE ACTIVITY IN TACHYCARDIA HEART-FAILURE

被引:23
作者
COLSTON, JT
KUMAR, P
CHAMBERS, JP
FREEMAN, GL
机构
[1] UNIV TEXAS,HLTH SCI CTR,DEPT MED,SAN ANTONIO,TX 78284
[2] AUDIE L MURPHY MEM VET ADM MED CTR,SAN ANTONIO,TX 78284
[3] UNIV TEXAS,DIV LIFE SCI,BRAIN RES LAB BIOCHEM,SAN ANTONIO,TX 78285
关键词
D O I
10.1016/0143-4160(94)90028-0
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Whether sarcolemmal (SL) calcium handling is altered in endstage heart failure produced by chronic rapid pacing is not known. To investigate this we paced 7 rabbits at a rate of 400 beats/min for 35 +/- 11 days. 6 animals served as non-paced controls. Purified left ventricular SL membranes were then prepared and tested for [H-3]-nitrendipine binding and (Ca2++Mg2+)-dependent ATPase (Ca2+-pump) activity. Results show a 50% reduction in calcium channel antagonist binding sites with B-max values reduced from 450 +/- 40 to 230 +/- 8 fmoles/mg protein in response to chronic rapid pacing (P < 0.01). This change was accompanied by a modest decrease in K-d from 0.29 +/- 0.09 to 0.22 +/- 0.03 nM (not significant). V-max values for the SL Ca2+-pump ATPase were decreased from 387 to 164 nmoles/mg protein/min (P < 0.01) with K-Ca(2+) values reduced from 0.91 to 0.28 mu M Ca2+ (P < 0.05) in response to tachycardia induced failure as compared to controls. ATPase activity in both groups was very sensitive to 25 mu M calmidazolium and 5 mu M vanadate. Results from this study indicate that both a reduction in SL calcium channel density and decrease in SL Ca2+-pump ATPase activity are evident in tachycardia heart failure. We conclude that sarcolemmal calcium handling is altered in heart failure induced by chronic rapid pacing and that such changes may contribute to systolic dysfunction associated with this model of heart failure.
引用
收藏
页码:349 / 356
页数:8
相关论文
共 28 条
[1]  
BERS DM, 1985, AM J PHYSIOL, V248, pH361
[2]   INTRACELLULAR CALCIUM HANDLING IN ISOLATED VENTRICULAR MYOCYTES FROM PATIENTS WITH TERMINAL HEART-FAILURE [J].
BEUCKELMANN, DJ ;
NABAUER, M ;
ERDMANN, E .
CIRCULATION, 1992, 85 (03) :1046-1055
[3]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[4]  
CARONI P, 1981, J BIOL CHEM, V256, P3263
[5]   THE EFFECTS OF PURIFIED MOJAVE TOXIN ON RAT SYNAPTIC MEMBRANE (CA+2+MG+2)-ATPASE AND THE DIHYDROPYRIDINE RECEPTOR [J].
CHAMBERS, JP ;
WAYNER, MJ ;
DUNGAN, J ;
RAEL, ED ;
VALDES, JJ .
BRAIN RESEARCH BULLETIN, 1986, 16 (05) :639-643
[6]   PLASMA NOREPINEPHRINE AS A GUIDE TO PROGNOSIS IN PATIENTS WITH CHRONIC CONGESTIVE HEART-FAILURE [J].
COHN, JN ;
LEVINE, TB ;
OLIVARI, MT ;
GARBERG, V ;
LURA, D ;
FRANCIS, GS ;
SIMON, AB ;
RECTOR, T .
NEW ENGLAND JOURNAL OF MEDICINE, 1984, 311 (13) :819-823
[7]   NITRENDIPINE BINDING IN CONGESTIVE HEART-FAILURE DUE TO MYOCARDIAL-INFARCTION [J].
DIXON, IMC ;
LEE, SL ;
DHALLA, NS .
CIRCULATION RESEARCH, 1990, 66 (03) :782-788
[9]  
FREEMAN GL, 1992, AM J PHYSIOL, V262, pH1939
[10]  
FREEMAN GL, 1992, AM J PHYSIOL, V262, pH56